Healthcare
Humana Inc.(HUM)
Live Price
Offline$379.22
+2.86% today
1Y Change
+50.57%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $28.39B
- Revenue Growth
- +10.1%
- EPS Growth
- -1.4%
- Dividend Yield
- 1.5%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Humana Inc. (HUM) is a Healthcare stock with a market cap of $28.39B and listed on NYSE. The stock last traded around $379.22 and up 50.6% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +10.1%, EPS growth of -1.4%, a dividend yield of 1.5%. What stands out right now is revenue +10.1%, EPS -1.4%, free cash flow -84.3% with operating margin 1.1% and ROIC 3.6%. The dividend is present but secondary, with a yield around 1.5%. Valuation is more restrained than many high-expectation growth names at P/E 25.2 and price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines HUM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+10.1% vs +7.6% peer median
Operating Margin
Below sector median
+1.1% vs +19.4% peer median
P/E
Below sector median
25.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
Q2 2026 was reported on Apr 29, 2026 with an EPS surprise of +1.1%.
The operating picture looks softer than before
Revenue is at +10.1% and EPS is at -1.4%, with operating margin around 1.1%.
The next real check-in already has a date
The next earnings event is scheduled for Jun 25, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.2% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 Apr 29, 2026 | +1.1% | -2.7% | +1.3% | +27.0% |
Q1 2026 Feb 11, 2026 | +0.8% | +2.0% | +8.6% | -6.7% |
Q4 2025 Nov 5, 2025 | +14.5% | -5.2% | -9.2% | -4.5% |
Benchmark Edge
HUM vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HUM
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HUM Max Drawdown
-47.54%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HUM and SPY.
Company Overview
Humana Inc.
New York Stock Exchange
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
- Leadership
- James A. Rechtin
- IPO Date
- Dec 31, 1981
- Employees
- 65.7k
- Street Address
- Humana Building
- Mailing
- Louisville, KY, 40202
- Region
- Louisville, KY, US
- Reporting Currency
- USD
- Investor Line
- 502 580 1000
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 25.2
- EV/EBITDA
- 13.1
- Price/Sales
- 0.2
- Price/Book
- 1.5
Growth
- Revenue
- +10.1%
- EPS
- -1.4%
- Free Cash Flow
- -84.3%
Profitability
- Gross Margin
- 14.0%
- Operating Margin
- 1.1%
- Net Margin
- 0.8%
- ROE
- 6.2%
- ROIC
- 3.6%
Balance Sheet
- Debt/Equity
- 0.75
- Current Ratio
- 1.77
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.